Yang Xuhua, Liu Honghai, Yang Jutian, Ma Zhongren, Guo Penghui, Chen Hong, Gao Dandan
China-Malaysia National Joint Laboratory, College of Life Sciences and Engineering, Northwest Minzu University, Lanzhou, China.
Technology Research and Development Center, Gansu Tobacco Industry Co., Ltd., Lanzhou, China.
Front Nutr. 2022 Sep 15;9:1013020. doi: 10.3389/fnut.2022.1013020. eCollection 2022.
(SLM) has been used as an herbal tea for treating stomach discomfort and indigestion for a long time in china. Polysaccharides have been identified as one of the major bioactive compounds in the SLM. In the present paper, ultrasonic-assisted enzymatic extraction (UAEE) method was employed in polysaccharides extraction derived from SLM using polyethylene glycol (PEG) as extraction solvent, two SLM polysaccharides (SLMPs) fractions (SLMPs-1-1 and SLMPs-2-1) were purified by DEAE Cellulose-52 and Sephadex G-100 chromatography in sequence. Then, the preliminarily structure of the two factions were characterized by chemical composition analysis, molecular weight measurement, UVS, HPLC-PMP, FT-IR, nuclear magnetic resonance (NMR) spectra analysis and SEM. The results showed that SLMPs-1-1 and SLMPs-2-1 with different molecular weights of 1.03 and 1.02 kDa, mainly composed of glucose (46.76 and 46.79%), respectively. The results of structural characterization from FT-IR, H NMR, and SEM revealed that SLMPs-1-1 and SLMPs-2-1 contained the typical pyranoid polysaccharide with α-glycosidic bond and β-glycosidic bond. Furthermore, it was found that SLMPs-1-1 could increase the levels of tumor necrosis factor-α (TNF-α) and interleukin-2 (IL-2), and alleviated the immune organs tissue damage of cyclophosphamide (Cy)-treated mice. RT-qPCR and Western-Blot analysis showed that SLMPs-1-1 could significantly up-regulated the levels of NF-κB, TLR4, which revealed that SLMPs-1-1 could participate in immunosuppressive protection of Cy-treated mice. These findings suggested that the potential of SLMPs-1-1 as an alternative immunostimulator could be used in food and pharmaceutical industries.
在中国,(某中药材名称,未明确写出,推测为SLM)长期以来一直被用作治疗胃部不适和消化不良的草药茶。多糖已被确定为该中药材中的主要生物活性化合物之一。在本文中,采用超声辅助酶提取(UAEE)法,以聚乙二醇(PEG)为提取溶剂从该中药材中提取多糖,通过DEAE纤维素-52和葡聚糖凝胶G-100柱色谱依次纯化得到两个该中药材多糖(SLMPs)级分(SLMPs-1-1和SLMPs-2-1)。然后,通过化学成分分析、分子量测定、紫外光谱(UVS)、高效液相色谱-对甲基苯磺酰肼(HPLC-PMP)、傅里叶变换红外光谱(FT-IR)、核磁共振(NMR)光谱分析和扫描电子显微镜(SEM)对这两个级分的初步结构进行了表征。结果表明,SLMPs-1-1和SLMPs-2-1的分子量分别为1.03和1.02 kDa,主要分别由葡萄糖组成(46.76%和46.79%)。傅里叶变换红外光谱(FT-IR)、氢核磁共振(H NMR)和扫描电子显微镜(SEM)的结构表征结果表明,SLMPs-1-1和SLMPs-2-1含有典型的具有α-糖苷键和β-糖苷键的吡喃型多糖。此外,发现SLMPs-1-1可以提高肿瘤坏死因子-α(TNF-α)和白细胞介素-2(IL-2)的水平,并减轻环磷酰胺(Cy)处理小鼠的免疫器官组织损伤。实时定量聚合酶链反应(RT-qPCR)和蛋白质免疫印迹(Western-Blot)分析表明,SLMPs-1-1可以显著上调核因子κB(NF-κB)、Toll样受体4(TLR4)的水平,这表明SLMPs-1-1可以参与环磷酰胺处理小鼠的免疫抑制保护作用。这些发现表明,SLMPs-1-1作为一种替代免疫刺激剂在食品和制药行业具有应用潜力。